All In Biotech

Free tool

FAERS Monitor: Leukeran

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 010669 or its brand name (Leukeran, Chlorambucil). Reports on generic versions are filed under their own applications.

Reports

3,931

Serious

3,662

93% of reports

Hospitalization

1,632

Death reported

929

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • neutropenia279
  • pneumonia272
  • off label use269
  • pyrexia243
  • drug ineffective204
  • thrombocytopenia199
  • anaemia164
  • febrile neutropenia162
  • disease progression156
  • acute myeloid leukaemia131
  • infection126
  • dyspnoea125
  • death116
  • nausea112
  • progressive multifocal leukoencephalopathy111

Reports by year received

View as table
YearReports
200447
200553
200635
200738
200871
200972
2010127
2011190
2012215
2013160
2014212
2015207
2016294
2017281
2018457
2019352
2020267
2021224
2022178
2023152
2024134
2025103
202662

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,228 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
progressive multifocal leukoencephalopathySignal11173.060.77,707
acute myeloid leukaemiaSignal13145.338.35,594
febrile neutropeniaSignal16213.111.31,799
neutropeniaSignal27911.09.82,537
thrombocytopeniaSignal1999.58.31,518
disease progressionSignal1567.16.1809
infectionSignal1264.73.9361
anaemiaSignal1644.64.0463
pneumoniaSignal2724.54.0747
pyrexiaSignal2433.83.3497
off label use2691.61.570
dyspnoea1251.21.03
drug ineffective2040.80.78
nausea1120.80.69
death1160.70.613

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.